{
    "Trade/Device Name(s)": [
        "Citrated: K, KH, RTH, FFH"
    ],
    "Submitter Information": "Haemonetics Corporation",
    "510(k) Number": "K232018",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150041"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "March 29, 2024",
    "Summary Letter Received Date": "July 7, 2023",
    "Submission Date": "July 6, 2023",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose System For In Vitro Coagulation Studies"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Whole blood hemostasis parameters (R, MA, LY30)",
        "Fibrinogen",
        "Platelet function",
        "Coagulation factor activity"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "TEG 6s Hemostasis Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Thromboelastography",
        "Optical detection",
        "Microfluidic assay cartridge"
    ],
    "Methodologies": [
        "Resonant frequency analysis",
        "Viscoelastic clot measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Analyzer",
        "System",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Citrated: K, KH, RTH, FFH assay cartridge and TEG 6s Hemostasis System for in vitro coagulation and hemostasis evaluation using thromboelastography",
    "Indications for Use Summary": "Intended for in vitro diagnostic evaluation of blood hemostasis properties in adult patients, including those with possible heparin/heparinoid presence and increased risk of coagulopathy, to assess hemorrhage or thrombosis before, during, and after cardiovascular surgery, procedures, or liver transplantation; usable in laboratory or point-of-care settings",
    "fda_folder": "Hematology"
}